Search research articles
Contact Us
Filters
Showing results (11-20 of 124) with videos related to
Page
of 13
Sort By:
Frontiers in Oncology
|
April 4, 2022
Second Primary Malignancies in Patients With Melanoma Subtypes: Analysis of 120,299 Patients From the SEER Database (2000-2016)
Asad Loya, Dan S Gombos, Sapna P Patel
Cancer
|
March 27, 2018
Obstacles to improving outcomes in the treatment of uveal melanoma
Katy K Tsai, Kathryn B Bollin, Sapna P Patel
Journal of Neuro-Oncology
|
April 29, 2018
Leptomeningeal disease in uveal melanoma: a case series
Isabella C Glitza, Sujan T Reddy, Sapna P Patel
Current Oncology Reports
|
February 22, 2022
25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions
Thach-Giao Truong, Lucy Boyce Kennedy, Sapna P Patel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 6, 2025
Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary
Sapna P Patel, Rahul A Sheth, Christina Davis, et al.
Frontiers in Oncology
|
April 11, 2022
Case Report: Neuromyelitis Optica After Treatment of Uveal Melanoma With Nivolumab and Ipilimumab
Karima Khimani, Sapna P Patel, Andrew Whyte, et al.
Medicine
|
January 31, 2016
GNA11 Mutation in a Patient With Cutaneous Origin Melanoma: A Case Report
Sapna P Patel, Dae Won Kim, Carol L Lacey, et al.
Melanoma Research
|
February 25, 2011
The left ventricle as the first site of uveal melanoma metastasis 13 years after treatment of the primary tumor
Nathalie A Kolandjian, Sapna P Patel, Nicholas E Papadopoulos, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 30, 2013
Surveillance options for patients with uveal melanoma following definitive management
Jasmine H Francis, Sapna P Patel, Dan S Gombos, et al.
Journal for Immunotherapy of Cancer
|
April 30, 2026
First-in-human use of recombinant IL-7 to potentiate antigen-specific T cell therapy: a single patient case study
Casey Bermack, Shailbala Singh, Guangsheng Pei, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 124) with videos related to
Sort By:
Page
of 13
Frontiers in Oncology
|
April 4, 2022
Second Primary Malignancies in Patients With Melanoma Subtypes: Analysis of 120,299 Patients From the SEER Database (2000-2016)
Asad Loya, Dan S Gombos, Sapna P Patel
Cancer
|
March 27, 2018
Obstacles to improving outcomes in the treatment of uveal melanoma
Katy K Tsai, Kathryn B Bollin, Sapna P Patel
Journal of Neuro-Oncology
|
April 29, 2018
Leptomeningeal disease in uveal melanoma: a case series
Isabella C Glitza, Sujan T Reddy, Sapna P Patel
Current Oncology Reports
|
February 22, 2022
25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions
Thach-Giao Truong, Lucy Boyce Kennedy, Sapna P Patel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 6, 2025
Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary
Sapna P Patel, Rahul A Sheth, Christina Davis, et al.
Frontiers in Oncology
|
April 11, 2022
Case Report: Neuromyelitis Optica After Treatment of Uveal Melanoma With Nivolumab and Ipilimumab
Karima Khimani, Sapna P Patel, Andrew Whyte, et al.
Medicine
|
January 31, 2016
GNA11 Mutation in a Patient With Cutaneous Origin Melanoma: A Case Report
Sapna P Patel, Dae Won Kim, Carol L Lacey, et al.
Melanoma Research
|
February 25, 2011
The left ventricle as the first site of uveal melanoma metastasis 13 years after treatment of the primary tumor
Nathalie A Kolandjian, Sapna P Patel, Nicholas E Papadopoulos, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 30, 2013
Surveillance options for patients with uveal melanoma following definitive management
Jasmine H Francis, Sapna P Patel, Dan S Gombos, et al.
Journal for Immunotherapy of Cancer
|
April 30, 2026
First-in-human use of recombinant IL-7 to potentiate antigen-specific T cell therapy: a single patient case study
Casey Bermack, Shailbala Singh, Guangsheng Pei, et al.
Page
of 13